Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Aug 6, 2022; 10(22): 7950-7959
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7950
Table 1 Review of the literature on primary spinal cord glioblastoma with qualified magnetic resonance images
Case No.
Ref.
Age/sex
Symptoms
Lesion location
Intramedullary only
Imaging findings
Surgery/therapy
Survival in month
1Ferrante et al[3], 202134 yr/FMW, SDNearly entire cervical spinal cord and medulla oblongata YesIsointense to hypointense on T1WI, isointense to hyperintense on T2WI, homogeneous enhancement NoneNR
64 yr/MMW, SDConus medullaris YesHyperintense on T2WI, peripheral enhancement, necrosis enhancing noduleSTR, radio/chemotherapy33
47 yr/MParesthesia, pain, MW, SDCervical and thoracicYesMultifocal lesion (C5-C7) and (T3-T5), peripheral enhancement, necrotic centerBiopsy, radio/chemotherapy10
2Shen et al[4], 202047 yr/FParesthesia, paralysisT12YesT12 nodular, isointense to hyperintense on T2WI, central significant enhancement surgical resection, NRNR
3Delgado et al[5], 201921 yr/FPain, weakness, paresthesiaT10-T12, L1Yes60 mm expansile mass, T10-T12 down to L1, nodular significant enhancementNTR, radio/chemotherapyRecurrence in 4 mo
4Chanchotisatien et al[6], 201927 yr/FDysuria, numbness, weakness, back PainT4-T12, T5-T12, respectivelyNoHomogenous, hyperintense T2WI, intra-/extramedullary regions from T4-T12 and T5-T12, respectively, homogenous enhancementBiopsy, radio/chemotherapyNR
5Caro-Osorio et al[7], 201848 yr/FNumbness, painC1-C3YesHypointense on T1WI, hyperintense on T2WI, heterogeneous enhancementSTR, radio/chemotherapy8
6Shen et al[1], 201715 yr/FNumbness, weaknessC4-C7YesHyperintense on T2WI, inhomogeneous enhancementNTR, radio/chemotherapy13
7Nunn et al[12], 201731 yr/MMW, SDT9-T2YesHyperintense on T2WI, spinal cord expanding, heterogeneous enhancementSurgical resection, radio/chemotherapy14
8Prasad et al[13], 201215 yr/FParaparesis, dysesthesia, urinary incontinence, SDC6-T7YesEnlargement of cord, heterogeneously enhancingSTR, radio/chemotherapy6
35 yr/MPain, paraplegia, urinary incontinence, SDT11-L1YesEnlargement of cord, heterogeneously enhancingNTR, radio/chemotherapy15